Adaptimmune Therapeutics Plc American...

ADAP

7.93

-0.48

-5.7%

After Hours:

7.93

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 8.16
Prev. Close: 8.41
Low/Hi: 7.79 - 8.20
52-Week: 3.76 - 9.29
Volumes
Equity: 567,538
90-Day Avg: 290,765
Option:
90-Day Avg: 46
Volatility
Todays Stock Vol: 66.7
20-Day (HV): 87.1
52-Week (HV): 71.8
30-Day IV: 58.8 -12.6
IV Pct Rank: 31% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 10-Nov (Est.)
P/E Ratio:
Market Cap: 786.5 M
Stock Type: Common
ADR:
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common - ADR | Sector: Healthcare | Industry: Biotechnology

ADAP Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income -20,215 -21,782 -15,414 -18,494
Change in Working Capital 1,959 -10,337 14,163 -35
Depreciation Amortization Depletion and Accretion 1,136 1,046 874 818
Deferred Taxes 0 0 0 0
Other Non-Cash Activities -889 2,634 2,747 2,345
Total Cash from Operating Activities -18,009 -28,439 2,370 -15,366
Capital Expenditures -8,963 -12,491 -6,921 -2,093
Other Investing Cash Flow -64,221 -10,146 23,880 7,836
Total Cash from Investing Activities -73,184 -22,637 16,959 5,743
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 41,801 61,397 17 0
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 0 0 0
Total Cash from Financing Activities 41,801 61,397 17 0
Exchange Rate Effects 0 0 -1,498 -831
Net Change in Cash -49,392 10,321 17,848 -10,454
Period Ending 31-Dec-2016
Net Income -71,579
Change in Working Capital 12,496
Depreciation Amortization Depletion and Accretion 3,286
Deferred Taxes 0
Other Non-Cash Activities 7,629
Total Cash from Operating Activities -48,168
Capital Expenditures -12,785
Other Investing Cash Flow 30,540
Total Cash from Investing Activities 17,755
Dividends and Distributions 0
Purchase or Sale of Stock 17
Purchase and Retirement of Debt 0
Other Financing Cash Flow 0
Total Cash from Financing Activities 17
Exchange Rate Effects -5,579
Net Change in Cash -35,975